Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Re-irradiation of High Grade Gliomas: a Quality of Life Study

NCT01711580 is registered in ClinicalTrials.gov with Maastricht Radiation Oncology as lead sponsor.

NCT NCT01711580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01711580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Re-irradiation of High Grade Gliomas: a Quality of Life Study
Lead sponsor
Maastricht Radiation Oncology
Phase
Observational
Overall status
Withdrawn
Start date
March 31, 2013
Completion date
September 30, 2015
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic astrocytoma, anaplastic oligoastrocytoma, glioblastoma multiforme